Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy

PURPOSE: Patients with primary immunodeficiency diseases (PIDD) are at increased risk of infection and may require lifelong immunoglobulin G (IgG) replacement. Infection incidence rates were determined for patients with PIDD receiving intravenously administered IgG (IGIV) in a home or hospital outpa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasserman, Richard L., Ito, Diane, Xiong, Yan, Ye, Xiaolan, Bonnet, Patrick, Li-McLeod, Josephine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325835/
https://www.ncbi.nlm.nih.gov/pubmed/28160239
http://dx.doi.org/10.1007/s10875-017-0371-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325835/
https://www.ncbi.nlm.nih.gov/pubmed/28160239
http://dx.doi.org/10.1007/s10875-017-0371-0

Ejemplares similares